Association Between Thyroid Function and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Case-Control Study.
La Clinica Terapeutica · 01.09.2026 · 177 (5) · 1079-1085
DOI: 10.7417/ct.2026.2108 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift La Clinica Terapeutica, erschienen am 01.09.2026. Verfasst von Ihab Anwar Orabi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Thyroid Gland.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated fatty liver disease (MAFLD) is highly prevalent among patients with type 2 diabetes mellitus (T2DM) and is closely linked to metabolic disturbances such as insulin resistance and dyslipidemia. Thyroid hormones play a critical role in regulating hepatic lipid metabolism and energy homeostasis; however, their relationship with MAFLD in diabetic populations remains incompletely defined.
Methods
In this case-control study, 150 patients with T2DM were enrolled, including 75 patients with MAFLD and 75 without MAFLD. Hepatic steatosis was confirmed using transient elastography with controlled attenuation parameter (CAP). Serum free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) were measured using chemiluminescent immunoassays. Clinical, anthropometric, and biochemical parameters were assessed. Multivariate logistic regression analysis was performed to identify independent predictors of MAFLD.
Results
Patients with MAFLD had significantly lower FT3 levels and higher TSH levels compared with diabetic controls without MAFLD (p = 0.016 and p < 0.001, respectively), while FT4 levels were comparable between groups. MAFLD was also associated with an adverse metabolic profile, including elevated triglycerides, total cholesterol, and low-density lipoprotein cholesterol, along with reduced high-density lipoprotein cholesterol (all p < 0.001). Liver enzymes were significantly higher in the MAFLD group. In multivariate analysis, elevated TSH (OR = 3.62, 95% CI: 1.21-10.84, p = 0.021) and triglycerides (OR = 1.43, 95% CI: 1.14-1.80, p = 0.002) were independently associated with MAFLD, whereas FT3 was not independently associated after adjustment.
Conclusions
Elevated TSH levels are independently associated with MAFLD in patients with T2DM, suggesting a link between thyroid function and hepatic steatosis beyond traditional metabolic risk factors. These findings highlight the potential role of thyroid function, particularly TSH, in the metabolic risk stratification of patients with diabetes and warrant further investigation into thyroid-liver interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
- Department of Internal Medicine, Faculty of Medicine, Tanta university, Tanta, Egypt.
- Geriatric Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Department of Internal Medicine, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
- Department of Diagnostic and Interventional Radiology and Molecular Imaging, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Department of Internal medicine and Rheumatology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Zitieren
APA
Orabi, I. A., Elhadidy, A. A., Amro, O. A. E. A., Attia, A. A., Abdelkader, A. A., Mohamed, E. S., Alsayyad, M. M. A. A., Sakr Elfors, A. F., Abdelmalak, M. W. M., Hegab, S. M. E. A., Rashwan, T. H., Ismail, H. A. M., Hegazy, H. A., & Mashaal, S. A. (2026). Association Between Thyroid Function and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Case-Control Study. La Clinica Terapeutica, 177(5), 1079-1085. https://doi.org/10.7417/ct.2026.2108
Vancouver
Orabi IA, Elhadidy AA, Amro OAEA, Attia AA, Abdelkader AA, Mohamed ES, et al. Association Between Thyroid Function and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Case-Control Study. La Clinica Terapeutica. 2026;177(5):1079-1085. doi:10.7417/ct.2026.2108
BibTeX
@article{Orabi2026,
author = {Orabi, Ihab Anwar and Elhadidy, Ahmed A and Amro, Ola Abd Elfattah Ali and Attia, Asmaa A and Abdelkader, Amr A and Mohamed, Elham Shabaan and Alsayyad, Mohammad Mossaad Abd Allah and Sakr Elfors, Ahmed Fakeih and Abdelmalak, Marian Wagieh Mansour and Hegab, Sherif Mohamed Elsayed Amin and Rashwan, Tamer Hassan and Ismail, Hatem Attia Mostafa and Hegazy, Hanan A and Mashaal, S A},
title = {Association Between Thyroid Function and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Case-Control Study},
journal = {La Clinica Terapeutica},
year = {2026},
volume = {177},
number = {5},
pages = {1079--1085},
doi = {10.7417/ct.2026.2108}
}
EUVIMED